Cargando…
Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: the LAURA Study
To determine whether the antihypertensive effectiveness of lercanidipine was independent of the different cardiovascular risk levels. Patients with treated or untreated mild-to-moderate essential hypertension were included in a multicentre, prospective, non-comparative, open-label study. Patients re...
Autores principales: | BARRIOS, V, ESCOBAR, C, NAVARRO, Á, BARRIOS, L, NAVARRO-CID, J, CALDERÓN, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1636683/ https://www.ncbi.nlm.nih.gov/pubmed/17073834 http://dx.doi.org/10.1111/j.1742-1241.2006.01176.x |
Ejemplares similares
-
Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine
por: Pruijm, Menno T, et al.
Publicado: (2008) -
Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
por: Barrios, Vivencio, et al.
Publicado: (2008) -
High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study
por: Barrios, V, et al.
Publicado: (2008) -
Lercanidipine in Hypertension
por: Borghi, Claudio
Publicado: (2005) -
Laura /
por: Baroja, Pío, 1872-1956
Publicado: (1981)